COVERAGE
July 21, 2022
Read time: 2 min
Sam Neel, Sarah Hogarth and Llewelyn Engel are featured in Law360 for representing AirBoss Defense Group LLC.
COVERAGE
July 21, 2022
Read time: 2 min
Paul Hughes and Debbie Green are featured in Law360 for representing two business groups are alleging the U.S. Securities and Exchange Commission’s recent rollback of rules governing proxy advisory firm.
COVERAGE
July 20, 2022
Read time: 2 min
Douglas Carsten, April Weisbruch, Judy Mohr, Jiaxiao Zhang, Mandy Kim and Art Dykhuis are featured in Law360 for representing United Theraputics.
COVERAGE
July 20, 2022
Read time: 3 min
International law firm McDermott Will & Emery represented Moffitt Cancer Center, a world leader in advancing cellular immunotherapies for the treatment of cancer, in its strategic alliance with Turnstone Biologics Corp., a clinical-stage biotechnology company developing next-generation immunotherapies to treat and cure solid tumors. Pursuant to this strategic alliance, which enhances and broadens the parties’ collaborative efforts to advance oncology research, Turnstone will have priority access to Moffitt’s scientific research, manufacturing, and clinical capabilities for the development of novel tumor infiltrating lymphocyte (TIL) therapies.
The parties also announced U.S. Food and Drug Administration clearance of an Investigational New Drug application for a Moffitt-sponsored Phase 1 clinical study of TIDAL-01, Turnstone’s lead TIL therapy candidate for cutaneous and non-cutaneous melanoma. The trial is expected to start late 2022.
The cross-border McDermott team includes Gary Davis, Jiayan Chen, Bob Louthian, Monika Richter and Richard Smith.
Read Moffitt’s press release.
McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices, industries and more than 20 locations to deliver highly effective solutions that propel success. More than 1,200 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.
COVERAGE
July 19, 2022
Read time: 2 min
Katharine O’Connor, Michelle Lowery and Stephen Wu are featured in Global Competition Review for serving as counsel to Southern Illinois Hospital Services.
DEAL ANNOUNCEMENT / PRESS RELEASE
July 19, 2022
Read time: 3 min
International law firm McDermott Will and Emery represented Portage Biotech Inc., a clinical-stage immuno-oncology company developing therapies to improve patient lives and increase survival by avoiding and overcoming cancer treatment resistance, in its agreement to acquire Tarus Therapeutics, a private company developing adenosine receptor antagonists.
Portage acquired Tarus in exchange for 2,425,999 shares of Portage along with the assumption of $3 million of Tarus’ liabilities. Portage will gain four best-in-class assets targeting different aspects of the adenosine pathway as part of the acquisition.
The McDermott team advising Portage is led by Bob Cohen and Eric Klee and includes Alex Laznovsky, Jeronimo Soares de Sousa, Myia Williams, Dan Zucker, Michael Siekman, Brian Malkin, Anisa Mohanty, Michelle Strowhiro and Daphne Trotter.
For more details, read Portage Biotech’s full press release here.
McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices, industries and more than 20 locations to deliver highly effective solutions that propel success. More than 1,200 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.
COVERAGE
July 19, 2022
Read time: 2 min
McDermott is featured in Global Legal Chronicle for representing Pasithea Therapeutics in its acquisition of Alpha-5 Integrin.
The McDermott deal team was led by Bob Cohen and Eric Klee and included Graciany Miranda, Jeronimo Soares de Sousa, Dan Zucker, Michael Siekman, Rodney Swartz, Todd Solomon, Evan Belosa, Nick Paul, David Saunders, Michelle Stowhiro, Abigail Kagan, Richard Bass and Brandon Sloane.
COVERAGE
July 19, 2022
Read time: 2 min
Warren Haskel, Richard Nicholson Jr., Joshua Simon and Dmitriy Tishyevich are featured in Law360 for representing Cigna.
COVERAGE
July 19, 2022
Read time: 2 min
Lisa Rumin, Jon Dubrow and Anthony Ferrara author this article in Law360 where they share background on the Antitrust Division of the U.S. Department of Justice’s complaint about Booz Allen Hamilton Holding Corp’s proposed acquisition of EverWatch Corp and they reflect the current DOJ’s aggressive approach to merger enforcement and introduce new theories that could affect other transactions.
COVERAGE
July 19, 2022
Read time: 2 min
Simon Airey is featured in Global Investigations Review for representing Shell’s former strategic investment advisor.
